Year |
Citation |
Score |
2024 |
Petersen-Cherubini CL, Liu Y, Deffenbaugh JL, Murphy SP, Xin M, Rau CN, Yang Y, Lovett-Racke AE. Dysregulated autotaxin expression by T cells in multiple sclerosis. Journal of Neuroimmunology. 387: 578282. PMID 38183947 DOI: 10.1016/j.jneuroim.2023.578282 |
0.362 |
|
2023 |
Petersen-Cherubini CL, Murphy SP, Xin M, Liu Y, Deffenbaugh JL, Jahan I, Rau CN, Yang Y, Lovett-Racke AE. Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis. European Journal of Immunology. e2350561. PMID 37850588 DOI: 10.1002/eji.202350561 |
0.373 |
|
2022 |
Gombash SE, Lee PW, Sawdai E, Lovett-Racke AE. Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective? Frontiers in Neurology. 13: 796933. PMID 35651353 DOI: 10.3389/fneur.2022.796933 |
0.461 |
|
2021 |
Kraus EE, Kakuk-Atkins L, Farinas MF, Jeffers M, Lovett-Racke AE, Yang Y. Regulation of autoreactive CD4 T cells by FoxO1 signaling in CNS autoimmunity. Journal of Neuroimmunology. 359: 577675. PMID 34403862 DOI: 10.1016/j.jneuroim.2021.577675 |
0.338 |
|
2021 |
Lovett-Racke AE, Yang Y, Liu Y, Gormley M, Kraus E, Graham C, Wray S, Racke MK, Alvarez E, Bass A, Fox E. B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report. Journal of Neuroimmunology. 359: 577676. PMID 34364105 DOI: 10.1016/j.jneuroim.2021.577676 |
0.305 |
|
2021 |
Aqel SI, Yang X, Kraus EE, Song J, Farinas MF, Zhao EY, Pei W, Lovett-Racke AE, Racke MK, Li C, Yang Y. A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg Balance. Jci Insight. PMID 33411696 DOI: 10.1172/jci.insight.142376 |
0.366 |
|
2020 |
Lee PW, Selhorst A, Lampe SG, Liu Y, Yang Y, Lovett-Racke AE. Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity. Frontiers in Neurology. 11: 19. PMID 32082243 DOI: 10.3389/fneur.2020.00019 |
0.363 |
|
2019 |
Lovett-Racke AE, Gormley M, Liu Y, Yang Y, Graham C, Wray S, Racke MK, Shubin R, Twyman C, Alvarez E, Bass A, Eubanks JL, Fox E. B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients. Journal of Neuroimmunology. 332: 187-197. PMID 31077854 DOI: 10.1016/J.Jneuroim.2019.04.017 |
0.323 |
|
2017 |
Lee PW, Severin ME, Lovett-Racke AE. TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis. European Journal of Immunology. PMID 28102541 DOI: 10.1002/eji.201646716 |
0.316 |
|
2016 |
Nuro-Gyina PK, Rieser EL, Granitto MC, Pei W, Liu Y, Lee PW, Aqel S, Zhang J, Lovett-Racke AE, Racke MK, Yang Y. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα. Journal of Neuroinflammation. 13: 302. PMID 27912762 DOI: 10.1186/s12974-016-0768-3 |
0.319 |
|
2016 |
Severin ME, Lee PW, Liu Y, Selhorst AJ, Gormley MG, Pei W, Yang Y, Guerau-de-Arellano M, Racke MK, Lovett-Racke AE. MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis. Brain : a Journal of Neurology. PMID 27190026 DOI: 10.1093/brain/aww084 |
0.306 |
|
2015 |
Yang Y, Winger RC, Lee PW, Nuro-Gyina PK, Minc A, Larson M, Liu Y, Pei W, Rieser E, Racke MK, Lovett-Racke AE. Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity. Clinical and Experimental Immunology. 179: 108-18. PMID 25142403 DOI: 10.1111/cei.12441 |
0.365 |
|
2015 |
Young NA, Wu L-, Amici S, Guerau M, Severin M, Lovett-Racke A, Valiente G, Burd C, Hampton J, Jarjour W. AB0050 Estrogen-Regulated STAT1 Activation Promotes TLR8 Overexpression and Facilitates Mirokine Signaling Via Exosomes Containing MIR-21 Endogenous Ligand: A Novel Innate Inflammatory Pathway in Systemic Lupus Erythematosus Annals of the Rheumatic Diseases. 74: 906-907. DOI: 10.1136/Annrheumdis-2015-Eular.4776 |
0.315 |
|
2014 |
Racke MK, Yang Y, Lovett-Racke AE. Is T-bet a potential therapeutic target in multiple sclerosis? Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 34: 623-32. PMID 25084179 DOI: 10.1089/jir.2014.0020 |
0.369 |
|
2014 |
Severin M, Guerau-de-arellano M, Lee P, Racke M, Lovett-racke A. Differentially expressed microRNAs in multiple sclerosis patients alter regulatory T cells Journal of Neuroimmunology. 275: 112-113. DOI: 10.1016/J.Jneuroim.2014.08.628 |
0.395 |
|
2014 |
Lee P, Smith A, Yang Y, Selhorst A, Racke M, Lovett-racke A. Critical contribution from antigen presenting cells for encephalitogenic T cells Journal of Neuroimmunology. 275: 65-66. DOI: 10.1016/J.Jneuroim.2014.08.173 |
0.338 |
|
2011 |
Guerau-de-Arellano M, Smith KM, Godlewski J, Liu Y, Winger R, Lawler SE, Whitacre CC, Racke MK, Lovett-Racke AE. Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain : a Journal of Neurology. 134: 3578-89. PMID 22088562 DOI: 10.1093/brain/awr262 |
0.336 |
|
2011 |
Lovett-Racke AE, Yang Y, Racke MK. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochimica Et Biophysica Acta. 1812: 246-51. PMID 20600875 DOI: 10.1016/j.bbadis.2010.05.012 |
0.311 |
|
2010 |
Hu W, Nessler S, Hemmer B, Eagar TN, Kane LP, Leliveld SR, Müller-Schiffmann A, Gocke AR, Lovett-Racke A, Ben LH, Hussain RZ, Breil A, Elliott JL, Puttaparthi K, Cravens PD, et al. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain : a Journal of Neurology. 133: 375-88. PMID 20145049 DOI: 10.1093/Brain/Awp298 |
0.366 |
|
2008 |
Yang Y, Gocke AR, Lovett-Racke A, Drew PD, Racke MK. PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis. Ppar Research. 2008: 546753. PMID 18645614 DOI: 10.1155/2008/546753 |
0.362 |
|
2007 |
Yang Y, Ratts RB, Hussain RZ, Northrop SC, Ben LH, Lovett-Racke A, Racke MK. CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE. European Journal of Immunology. 37: 2032-42. PMID 17559172 DOI: 10.1002/Eji.200636971 |
0.34 |
|
2006 |
Ratts RB, Karandikar NJ, Hussain RZ, Choy J, Northrop SC, Lovett-Racke AE, Racke MK. Phenotypic characterization of autoreactive T cells in multiple sclerosis. Journal of Neuroimmunology. 178: 100-10. PMID 16901549 DOI: 10.1016/j.jneuroim.2006.06.010 |
0.319 |
|
2006 |
Racke MK, Gocke AR, Muir M, Diab A, Drew PD, Lovett-Racke AE. Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis. The Journal of Nutrition. 136: 700-3. PMID 16484546 DOI: 10.1093/Jn/136.3.700 |
0.354 |
|
2006 |
Hansen BS, Hussain RZ, Lovett-Racke AE, Thomas JA, Racke MK. Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. Journal of Neuroimmunology. 172: 94-103. PMID 16360885 DOI: 10.1016/j.jneuroim.2005.11.006 |
0.323 |
|
2005 |
Muir MT, Lovett-Racke AE, Racke MK. Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosis. Expert Review of Clinical Immunology. 1: 345-55. PMID 20476986 DOI: 10.1586/1744666X.1.3.345 |
0.335 |
|
2002 |
Lovett-Racke AE, Racke MK. Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells. Cellular Immunology. 215: 54-60. PMID 12142036 |
0.331 |
|
2002 |
Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 168: 2508-15. PMID 11859145 DOI: 10.4049/Jimmunol.168.5.2508 |
0.38 |
|
2000 |
Racke MK, Ratts RB, Arredondo L, Perrin PJ, Lovett-Racke A. The role of costimulation in autoimmune demyelination Journal of Neuroimmunology. 107: 205-215. PMID 10854658 DOI: 10.1016/S0165-5728(00)00230-7 |
0.44 |
|
2000 |
Peters TR, Bodine DM, McDonagh KT, Lovett-Racke A, McFarland HF, McFarlin DE, Nienhuis AW, Racke MK. Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 103: 51-62. PMID 10674989 DOI: 10.1016/S0165-5728(99)00181-2 |
0.334 |
|
1999 |
Perrin PJ, Lovett-Racke A, Phillips SM, Racke MK. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis. Histology and Histopathology. 14: 1269-76. PMID 10506942 DOI: 10.14670/HH-14.1269 |
0.381 |
|
1998 |
Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. The Journal of Clinical Investigation. 101: 725-30. PMID 9466965 DOI: 10.1172/Jci1528 |
0.32 |
|
1998 |
Lovett-Racke A, Trotter J, Lauber J, Perrin P, June C, Racke M. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients Journal of Neuroimmunology. 90: 75. DOI: 10.1016/S0165-5728(98)91630-7 |
0.381 |
|
Show low-probability matches. |